Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination therapy of tolterodine and tamsulosin for stent-related urinary symptoms
IRCT20190119042410N1Phase 3Completed
- Sponsor
- Bushehr University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tolterodine and tamsulosin, sponsored by Bushehr University of Medical Sciences. Started Oct 2019; status: completed.
02
Drugs
tolterodinetamsulosin
Beyond the preview
Go deeper on IRCT20190119042410N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190119042410N1.